GMMMG

Licensed for use as a disease modifying anti-rheumatic drug in rheumatoid arthritis, discoid, systemic lupus erythematosus, and other rheumatic conditions e.g. connective tissue disorder, Sjogren’s syndrome. 3. Criteria for shared care. Prescribing responsibility will only be transferred when. Treatment is for a specified indication. ................
................